Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans
about
Diagnosis of lyme borreliosis.Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implicationsTemporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and miceThe Past, Present, and (Possible) Future of Serologic Testing for Lyme DiseaseCurrent Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States.The Borrelia burgdorferi 37-kilodalton immunoblot band (P37) used in serodiagnosis of early lyme disease is the flaA gene product.Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitisStrong IgG antibody responses to Borrelia burgdorferi glycolipids in patients with Lyme arthritis, a late manifestation of the infection.Diagnostic challenges of early Lyme disease: lessons from a community case seriesLyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein.Immunoglobulin M capture assay for serologic confirmation of early Lyme disease: analysis of immune complexes with biotinylated Borrelia burgdorferi sonicate enhanced with flagellin peptide epitopeEarly Lyme disease with spirochetemia - diagnosed by DNA sequencing.Lymphoadenopathy during lyme borreliosis is caused by spirochete migration-induced specific B cell activationSeroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York.Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferiDelays and diversions mark the development of B cell responses to Borrelia burgdorferi infection.Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation.Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.Probable late lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection.An Enhanced ELISPOT Assay for Sensitive Detection of Antigen-Specific T Cell Responses to Borrelia burgdorferi.Recombinant BBK32 protein in serodiagnosis of early and late Lyme borreliosis.Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings.A twist on Lyme: the challenge of diagnosing European Lyme neuroborreliosis.Laboratory testing for Lyme disease: possibilities and practicalities.A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease.Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteinsA prospective study among patients presenting at the general practitioner with a tick bite or erythema migrans in The Netherlands.CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection.Health care costs, utilization and patterns of care following Lyme disease.Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots.Chronic Lyme disease: misconceptions and challenges for patient managementSuppression of Long-Lived Humoral Immunity Following Borrelia burgdorferi InfectionEpidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013Dynamic longitudinal antibody responses during Borrelia burgdorferi infection and antibiotic treatment of rhesus macaquesLyme disease: Is it or is it not?Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.Lyme disease testing by large commercial laboratories in the United States.Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.Early diagnosis and treatment of patients with symptomatic acute Q fever do not prohibit IgG antibody responses to Coxiella burnetii.New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol
P2860
Q22242237-8BE2A516-D126-4B4E-9FA2-36F93E969063Q24550721-0B610DE7-CCEF-48F6-B936-E1B13949E7C9Q24550778-16F48535-14B1-4216-942B-A7D434F65EF6Q28075680-F463EB42-572B-48BE-85F6-538F05DB31EFQ30357899-5C7EE4B5-3807-4AFC-A28E-EB17D0E61E63Q31906497-513CD9B4-E531-4B11-878C-D4AE36DD4B1EQ33261311-5B075C73-2B6F-4CE4-BF72-AE760723EF1AQ33426217-6936007B-FF60-418F-B34F-CC7DB14CE01AQ33457704-ACC86860-CD24-4973-B60A-844FC3E5B0A2Q33597989-6FB58F0C-9B44-47BD-91E1-7736AB7B38F8Q33662007-9B86C167-C8EE-4FFA-86FC-1D4A76C70153Q33735340-00BD05A0-1C47-4EF5-B52C-B1A62FB981D5Q33921243-21CC7EDF-CDDE-4103-A945-FE21613F86B7Q33960957-8C2D4367-5F06-4028-B0EB-938914DBFAE5Q33973394-A2C29D58-38BC-4903-A4DD-DAC2356C5325Q34031718-C06D0A76-7213-4846-A346-CDF9CFFE95F7Q34298182-0A451630-4040-4C2E-B4D2-E85970474D4CQ34336214-F4AC653B-279C-4AE5-BCED-C89C3D0ADE2EQ34361740-4E5500EE-EBA0-41A0-B5A1-D7A9C9D986F9Q34414046-5B4AF6A3-45F3-4D62-B49A-43C365D46ADAQ34453998-04E667C6-A7C1-4F3D-B574-02F8AE1C52C2Q34456092-14B1C3B9-F70D-4EBF-A8CB-6BD97D84F5E1Q34487621-1C48CC22-73D2-401D-B5AE-725087E056C1Q34515948-6424DFA1-EF29-4D12-AF17-F640FA6DAB34Q34601381-598F4D19-3630-445B-8E47-55E46EEFDC4AQ34721407-227A8088-5845-40C0-88E6-34BDD10A7073Q34734155-CDEAEDF0-9476-4246-B731-08C9FE814DF1Q34890094-87AB7E20-4416-4D74-ACF4-2F5B23EC6A89Q35049415-75D52365-676E-4CC7-8260-374D5DEBE3EEQ35093956-625D2E64-C154-4567-BA46-92D332E40ED7Q35633278-F34BA74E-1219-4295-B4EB-FED67F56FA94Q35681353-C9686E6E-F890-43BC-9725-87D707A9DD06Q36121502-2F2AFEA0-CD4E-4BF3-85FB-7E8E28F462E1Q36154732-35059A48-ADCF-4F03-BC0B-605124A5B2CCQ36170946-DC6D5A17-0810-4249-9818-BE1414445A8CQ36253022-2D2004D2-6A65-4B32-A1FD-E3BE0E6053B4Q36283952-EBA029E4-7C15-4F61-ACE4-E49EF9E7BA9CQ36297670-1922D12A-7FC4-44DB-80E8-BB351267023FQ36362272-827DC8BB-E796-4EC5-840E-D715D4CB1AEDQ36539038-E94F187A-6F00-47C0-AC8C-6562C3070599
P2860
Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Evolution of the serologic res ...... ure-confirmed erythema migrans
@ast
Evolution of the serologic res ...... ure-confirmed erythema migrans
@en
type
label
Evolution of the serologic res ...... ure-confirmed erythema migrans
@ast
Evolution of the serologic res ...... ure-confirmed erythema migrans
@en
prefLabel
Evolution of the serologic res ...... ure-confirmed erythema migrans
@ast
Evolution of the serologic res ...... ure-confirmed erythema migrans
@en
P2093
P2860
P1476
Evolution of the serologic res ...... ure-confirmed erythema migrans
@en
P2093
G P Wormser
J Nowakowski
M E Aguero-Rosenfeld
R B Nadelman
P2860
P407
P577
1996-01-01T00:00:00Z